Biovac in talks to make Covid-19 vaccines in SA
The company says it has the capacity to make 20-million to 30-million vaccines a year, depending on the technology involved
State-backed vaccine developer Biovac is in discussion with several pharmaceutical companies developing Covid-19 vaccines to potentially manufacture shots in SA, CEO Morena Makhoana said on Thursday.
The public-private partnership was established in 2003 to revive SA’s human vaccine manufacturing capabilities, with the state owning 47.5% and the majority stake held by a private consortium led by Immunotek. Earlier in November it began manufacturing Sanofi Pasteur’s six-in-one paediatric vaccine Hexaxim, the first time since the mid-1990s that sterile human vaccines have been made in SA...